Livnexa Institute for Peptides Research

5-Amino-1MQ is a small molecule peptide that works by inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme that plays a crucial role in regulating fat metabolism and energy expenditure. By boosting cellular NAD+ production, it improves mitochondrial function and metabolic rate at rest, enhancing the body's natural fat-burning capabilities even without intense physical activity.

AOD-9604 is a synthetic peptide derived from a modified fragment of human growth hormone (HGH), specifically designed to promote fat loss. Comprising amino acids 176-191 of the GH molecule, it mimics the fat-burning domain of growth hormone without stimulating muscle growth or affecting blood sugar levels. This peptide works by enhancing lipolysis (fat breakdown) and inhibiting lipogenesis (fat accumulation), making it an effective tool for targeting stubborn fat deposits.

CJC-1295 + Ipamorelin is a highly effective peptide combination designed to stimulate the body's natural growth hormone (GH) release in a controlled and sustained manner. CJC-1295 (a GHRH analog) increases the amplitude and duration of GH pulses by stimulating GHRH receptors in the pituitary gland, while Ipamorelin (a ghrelin receptor agonist) enhances the frequency of GH release without significantly raising cortisol or prolactin. This synergy creates an optimal anabolic environment for muscle growth, fat loss, and recovery.

Tesamorelin is a synthetic peptide and Growth Hormone-Releasing Hormone (GHRH) analog, FDA-approved for reducing visceral adipose tissue (VAT) in HIV-associated lipodystrophy. By stimulating the pituitary gland to increase natural growth hormone (GH) and IGF-1 production, it selectively targets dangerous belly fat while preserving muscle mass. This makes it particularly effective for body recomposition during cutting phases or for individuals with metabolic concerns related to visceral fat accumulation.

BPC-157 is a pentadecapeptide derived from a protective protein found in the stomach, renowned for its powerful regenerative and healing properties. It promotes rapid repair of muscles, tendons, ligaments, nerves, and even the gut lining by accelerating angiogenesis (new blood vessel formation), reducing inflammation, and enhancing cellular migration to injury sites. This makes it especially valuable for athletes recovering from injuries and individuals dealing with chronic inflammatory conditions.

TB-500 (Thymosin Beta-4) is a naturally occurring peptide that promotes wound healing, tissue repair, and recovery through multiple mechanisms. It supports cell migration to injury sites, reduces inflammation, and accelerates healing across various tissue types including muscle, tendon, ligament, and even cardiac tissue. TB-500 is particularly effective for chronic injuries, post-surgical recovery, and systemic recovery enhancement.

Retatrutide is a groundbreaking triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, making it one of the most advanced and effective peptides for fat loss and metabolic improvement. By addressing multiple hormonal pathways at once, it enhances satiety, increases energy expenditure, improves glucose metabolism, and promotes significant fat loss. Early clinical trials report up to 24.2% total body weight loss over 48 weeks, representing a paradigm shift in metabolic optimization.

Tirzepatide is a dual GLP-1 and GIP receptor agonist that enhances insulin secretion, reduces appetite, and delays gastric emptying. By activating both incretin pathways, it offers superior weight loss compared to GLP-1 agonists alone while also improving metabolic markers. Clinical trials report up to 25.3% weight loss over 88 weeks, making it one of the most effective pharmacological weight loss interventions available. It balances appetite control with metabolic optimization for sustainable fat loss.

Semaglutide is a GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and enhances insulin secretion. FDA-approved for both type 2 diabetes and chronic weight management, it helps reduce caloric intake effortlessly while managing blood sugar levels. Studies show an average 15.2% weight loss over 104 weeks, making it ideal for steady, controlled fat loss with minimal disruption to daily life. Its once-weekly dosing and proven track record make it a popular first-line option.